Skip to content

Observational Study About the Use of Fibrinogen in Adult Cardiac Surgery

FibCard Study: Observational Study About the Use of Fibrinogen in Adult Cardiac Surgery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03075774
Enrollment
3000
Registered
2017-03-09
Start date
2017-03-31
Completion date
2018-04-30
Last updated
2017-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery, Extracorporeal Circulation, Fibrinogen

Brief summary

Multicenter prospective observational study, involving all adult patients who underwent cardiac surgery with extracorporeal circulation

Interventions

None listed

Sponsors

Keyrus Biopharma
CollaboratorOTHER
Société Française d'Anesthésie et de Réanimation
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patient over the age of 18 that underwent a cardiac surgery with extracorporeal circulation. * Patient who agreed to participate in the study.

Exclusion criteria

* Patient under the age of 18.

Design outcomes

Primary

MeasureTime frameDescription
The international recommendations published by ESA in 201613 MonthsReview the concordance between the presence / absence of indication (according to the international recommendations published by ESA in 2016) and the prescription / non-prescription of fibrinogen concentrates

Contacts

Primary ContactLongrois Dan, Pr
dan.longrois@aphp.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026